Table: Shin Nippon Biomedical -2018/19 group results

Shin Nippon Biomedical Laboratories

10/05/2019 07:15

May 10 (Reuters)- 
          Shin Nippon Biomedical Laboratories Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2019    Mar 31, 2018   Mar 31, 2020     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           15.66           16.60          14.47         5.99    
               (-5.7 pct)      (-3.7 pct)     (-7.6 pct)   (-32.6 pct) 
  Operating      829 mln      loss 697 mln        1.50        69 mln   
                                              (+80.8 pct)              
  Recurring        1.61       loss 813 mln        1.55        97 mln   
                                              (-3.9 pct)   (-89.0 pct) 
  Net
  Net              1.95         loss 3.56         1.25        22 mln   
                                              (-35.9 pct)  (-97.6 pct) 
  EPS           46.84 yen    loss 85.41 yen    30.02 yen     0.52 yen  
  Ann Div          NIL             NIL                                 
  -Q2 Div          NIL             NIL                                 
  -Q4 Div          NIL             NIL                                 
  
  NOTE - Shin Nippon Biomedical Laboratories Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2395.T